Primary sclerosing cholangitis: summary of a workshop (Q36581592)

15 August 2017

1 reference

title

Primary sclerosing cholangitis: summary of a workshop (English)

1 reference

15 August 2017

0 references

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

4

Gregory J Gores

1 reference

15 August 2017

Nicholas F LaRusso

1

1 reference

15 August 2017

Benjamin L Shneider

2

1 reference

15 August 2017

Dennis Black

3

1 reference

15 August 2017

Stephen P James

5

1 reference

15 August 2017

Edward Doo

6

1 reference

15 August 2017

Jay H Hoofnagle

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

44

1 reference

15 August 2017

746-764

1 reference

15 August 2017

3

1 reference

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study

15 August 2017

1 reference

Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium

21 January 2018

1 reference

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.

21 January 2018

1 reference

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

21 January 2018

1 reference

7 January 2021

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

1 reference

7 January 2021

Primary sclerosing cholangitis.

1 reference

7 January 2021

Sclerosing cholangitis

1 reference

7 January 2021

1 reference

7 January 2021

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.

1 reference

7 January 2021

Small-duct primary sclerosing cholangitis

1 reference

7 January 2021

Small-duct primary sclerosing cholangitis: a long-term follow-up study

1 reference

7 January 2021

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis

1 reference

7 January 2021

Epidemiology of primary sclerosing cholangitis

1 reference

7 January 2021

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

7 January 2021

Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome.

1 reference

7 January 2021

Primary sclerosing cholangitis in children

1 reference

7 January 2021

Liver involvement in the histiocytic disorders of childhood.

1 reference

7 January 2021

Liver disease in children with primary immunodeficiencies

1 reference

7 January 2021

Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study.

1 reference

7 January 2021

Neonatal sclerosing cholangitis in two siblings: a category of progressive intrahepatic cholestasis

1 reference

7 January 2021

Sclerosing cholangitis in children

1 reference

7 January 2021

Primary sclerosing cholangitis in children: a long-term follow-up study

1 reference

7 January 2021

Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

1 reference

7 January 2021

Primary sclerosing cholangitis in childhood

1 reference

7 January 2021

Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children

1 reference

7 January 2021

Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).

1 reference

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

7 January 2021

Primary sclerosing cholangitis: refinement and validation of survival models

1 reference

7 January 2021

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

7 January 2021

The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis

1 reference

7 January 2021

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

1 reference

7 January 2021

Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom

1 reference

7 January 2021

Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

1 reference

7 January 2021

Clinical profile of primary sclerosing cholangitis in Singapore

1 reference

7 January 2021

Prevalence of autoimmune liver disease in Alaska Natives

1 reference

7 January 2021

Primary sclerosing cholangitis: an experience from India

1 reference

7 January 2021

Primary sclerosing cholangitis in Japan--analysis of 192 cases

1 reference

7 January 2021

Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease

1 reference

7 January 2021

1 reference

7 January 2021

Review article: current management of primary sclerosing cholangitis

1 reference

7 January 2021

Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis

1 reference

7 January 2021

Is there a role for liver biopsy in primary sclerosing cholangitis?

1 reference

7 January 2021

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

1 reference

7 January 2021

Sclerosing cholangitis in the paediatric patient

1 reference

7 January 2021

Primary sclerosing cholangitis: findings on cholangiography and pancreatography

1 reference

7 January 2021

Primary sclerosing cholangitis: MR imaging findings with pathologic correlation

1 reference

7 January 2021

Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis

1 reference

7 January 2021

Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis

1 reference

7 January 2021

1 reference

7 January 2021

Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply

1 reference

7 January 2021

The cholangiopathies: disorders of biliary epithelia

1 reference

7 January 2021

Cholangiocyte biology

1 reference

7 January 2021

Genetics of liver disease: immunogenetics and disease pathogenesis

1 reference

7 January 2021

Increased prevalence of primary sclerosing cholangitis among first-degree relatives

1 reference

7 January 2021

Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis

1 reference

7 January 2021

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism

1 reference

7 January 2021

BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.

1 reference

7 January 2021

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease

1 reference

7 January 2021

Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis

1 reference

7 January 2021

Animal models for primary sclerosing cholangitis

1 reference

7 January 2021

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

1 reference

7 January 2021

Molecular pathogenesis of cholestasis.

1 reference

7 January 2021

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

1 reference

7 January 2021

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

1 reference

7 January 2021

ABCB4 gene mutations and primary sclerosing cholangitis.

1 reference

7 January 2021

Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis

1 reference

7 January 2021

Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis

1 reference

7 January 2021

Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis

1 reference

7 January 2021

Proinflammatory cytokines inhibit secretion in rat bile duct epithelium.

1 reference

7 January 2021

Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes

1 reference

7 January 2021

Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation.

1 reference

7 January 2021

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

1 reference

7 January 2021

Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis

1 reference

7 January 2021

Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis.

1 reference

7 January 2021

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

1 reference

7 January 2021

1 reference

7 January 2021

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass

1 reference

7 January 2021

MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)

1 reference

7 January 2021

The current future understanding of inflammatory bowel disease

1 reference

7 January 2021

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

1 reference

7 January 2021

NOD-LRR proteins: role in host-microbial interactions and inflammatory disease

1 reference

7 January 2021

Lipopolysaccharide Activates Nuclear Factor-KappaB through Toll-Like Receptors and Related Molecules in Cultured Biliary Epithelial Cells

1 reference

7 January 2021

Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: a mechanism for post-liver transplantation cholangitis?

1 reference

7 January 2021

Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis

1 reference

7 January 2021

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

1 reference

7 January 2021

Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.

1 reference

7 January 2021

Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease

1 reference

7 January 2021

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

1 reference

7 January 2021

Chemokines in lymphocyte trafficking and intestinal immunity

1 reference

7 January 2021

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

1 reference

7 January 2021

CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver

1 reference

7 January 2021

Management of primary sclerosing cholangitis

1 reference

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

7 January 2021

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

7 January 2021

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

1 reference

7 January 2021

1 reference

7 January 2021

Steroid-responsive (autoimmune?) sclerosing cholangitis

1 reference

7 January 2021

Toward better treatment of primary sclerosing cholangitis

1 reference

7 January 2021

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

7 January 2021

Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

1 reference

7 January 2021

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study

1 reference

7 January 2021

Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.

1 reference

7 January 2021

Primary sclerosing cholangitis: resect, dilate, or transplant?

1 reference

7 January 2021

Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis

1 reference

7 January 2021

Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment

1 reference

7 January 2021

Therapeutic investigations in primary sclerosing cholangitis

1 reference

7 January 2021

Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis

1 reference

7 January 2021

Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis

1 reference

7 January 2021

Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis

1 reference

7 January 2021

Endoscopic management of biliary tract strictures in primary sclerosing cholangitis

1 reference

7 January 2021

Four years experience with short term stenting in primary sclerosing cholangitis

1 reference

7 January 2021

Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group

1 reference

7 January 2021

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease

1 reference

7 January 2021

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

1 reference

7 January 2021

Pirfenidone in the treatment of primary sclerosing cholangitis

1 reference

7 January 2021

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

1 reference

7 January 2021

Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models.

1 reference

7 January 2021

A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease

1 reference

7 January 2021

Results of the first year of the new liver allocation plan

1 reference

7 January 2021

The survival benefit of liver transplantation

1 reference

7 January 2021

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

1 reference

7 January 2021

Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?

1 reference

7 January 2021

Biliary strictures after liver transplantation: clinical picture, correlates and outcomes

1 reference

7 January 2021

Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?

1 reference

7 January 2021

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience

1 reference

7 January 2021

Recurrence of primary sclerosing cholangitis after liver transplantation

1 reference

7 January 2021

Graft Failure From Severe Recurrent Primary Sclerosing Cholangitis Following Orthotopic Liver Transplantation

1 reference

7 January 2021

Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study

1 reference

7 January 2021

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

1 reference

7 January 2021

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

1 reference

7 January 2021

Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens

1 reference

7 January 2021

De-Novo Cholangiocarcinoma in the Setting of Recurrent Primary Sclerosing Cholangitis Following Liver Transplant

1 reference

7 January 2021

Colon carcinoma in patients undergoing liver transplantation

1 reference

7 January 2021

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

1 reference

7 January 2021

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

1 reference

7 January 2021

Worldwide trends in mortality from biliary tract malignancies

1 reference

7 January 2021

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy

1 reference

7 January 2021

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

1 reference

7 January 2021

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

1 reference

7 January 2021

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis

1 reference

7 January 2021

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment

1 reference

7 January 2021

Early detection and treatment of cholangiocarcinoma

1 reference

7 January 2021

Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience

1 reference

7 January 2021

Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

7 January 2021

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

7 January 2021

Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes

1 reference

7 January 2021

Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis

1 reference

7 January 2021

Is liver transplantation indicated for cholangiocarcinoma?

1 reference

7 January 2021

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation

1 reference

7 January 2021

Extended indications in living-donor liver transplantation: bile duct cancer.

1 reference

7 January 2021

[Surgical therapy of hilar cholangiocarcinoma]

1 reference

7 January 2021

Liver transplantation for cholangiocarcinoma: results in 207 patients

1 reference

7 January 2021

Surgical treatment in proximal bile duct cancer. A single-center experience

1 reference

7 January 2021

Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature

1 reference

7 January 2021

Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma

1 reference

7 January 2021

Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21337

1 reference

15 August 2017

1 reference